Lisa is a participant in the NEON Trial. This international clinical trial is investigating whether an immunotherapy drug can help the body’s own immune system to fight cancer cells, in women with triple-negative breast cancer. The trial will determine if the drug is safe and effective in treating this type of breast cancer before surgery.
Six months after receiving a clear mammogram, Lisa felt a lump in her breast. After getting the lump checked by a doctor, and undergoing further scans, Lisa was diagnosed with triple negative breast cancer, a less common and more aggressive form of breast cancer. She was 49 years old.